BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1750073)

  • 21. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
    Clements PJ; Peter JB; Agopian MS; Telian NS; Furst DE
    J Rheumatol; 1990 Jul; 17(7):908-10. PubMed ID: 2213757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neopterin and interferon gamma serum levels in renal allograft recipients.
    Khoss AE; Balzar E; Steger H; Howanietz H; Wladika W; Hamilton G; Woloszczuk W
    Child Nephrol Urol; 1988-1989; 9(1-2):46-9. PubMed ID: 3150820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients.
    Svendsen U; Larsen K; Allermand H; Thayssen P; Jensen S; Pettersson G
    Transplant Proc; 1995 Dec; 27(6):3477. PubMed ID: 8540057
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
    Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
    Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune monitoring: does the reality fulfill the promise?
    Tice DG; Heintz S; Scruggs B; Hubbell C; Szmalc FS
    Transplant Proc; 1993 Aug; 25(4):2654. PubMed ID: 8356709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tracheobronchial healing after lung and heart-lung transplantations. Apropos of 64 anastomoses].
    Giudicelli R; Le Mee F; Thomas P; Reynaud M; Garbe L; Camillieri S; Badier M; Viard L; Barthélemy A; Auffray JP
    Ann Cardiol Angeiol (Paris); 1994 Sep; 43(7):380-3. PubMed ID: 7993031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
    Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
    Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.
    Ballantyne CM; Mainolfi EA; Young JB; Windsor NT; Cocanougher B; Lawrence EC; Pollack MS; Entman ML; Rothlein R
    J Heart Lung Transplant; 1994; 13(4):597-603. PubMed ID: 7947875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of neopterin by a commercial radioimmunoassay in aortocoronary bypass surgery and heart transplantation].
    Vogt S; Hippe K
    Z Med Lab Diagn; 1991; 32(3-4):193-6. PubMed ID: 1897298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of lung allograft rejection.
    Lawrence EC
    Clin Chest Med; 1990 Jun; 11(2):269-78. PubMed ID: 2189662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy.
    Young JB; Lloyd KS; Windsor NT; Cocanougher B; Weilbaecher DG; Kleiman NS; Smart FW; Nelson DL; Lawrence EC
    J Heart Lung Transplant; 1991; 10(2):243-50. PubMed ID: 2031920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage.
    Abendroth D; Storck M; Techt B; Zavazava N
    Transplant Proc; 1995 Dec; 27(6):3114-5. PubMed ID: 8539869
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
    Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
    J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients.
    Chan CC; Abi-Saleh WJ; Arroliga AC; Stillwell PC; Kirby TJ; Gordon SM; Petras RE; Mehta AC
    J Heart Lung Transplant; 1996 Feb; 15(2):196-205. PubMed ID: 8672524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liberation of neopterin after lung resecting interventions with and without bronchial carcinoma].
    Gebhard F; Lenz J; Brückner UB
    Chirurg; 1996 Jul; 67(7):725-9. PubMed ID: 8776545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic juice neopterin excretion--reliable marker for detection of pancreatic allograft rejection.
    Königsrainer A; Reibnegger G; Ofner D; Klima G; Tauscher T; Margreiter R
    Transplant Proc; 1990 Apr; 22(2):671-2. PubMed ID: 1691547
    [No Abstract]   [Full Text] [Related]  

  • 40. Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation.
    Snell GI; Boehler A; Glanville AR; McNeil K; Scott JP; Studer SM; Wallwork J; Westall G; Zamora MR; Stewart S
    J Heart Lung Transplant; 2007 May; 26(5):423-30. PubMed ID: 17449409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.